Induction of reporter gene expression by inhibitors of histone deacetylase

Anticancer Research

Volumn 18, Issue 4 A, 1998, Pages 2717-2721

  Lea, Michael A ^a   Randolph, Verrell M ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Butyrate; Histone acetylation; Phenylbutyrate; Reporter gene expression; Trichostatin A

Indexed keywords

ARYLBUTYRIC ACID DERIVATIVE; BUTYRIC ACID; HISTONE DEACETYLASE; TRICHOSTATIN A;

ACETYLATION; ANIMAL CELL; ARTICLE; GENE EXPRESSION; NONHUMAN; OSTEOSARCOMA CELL; PRIORITY JOURNAL; RAT; REPORTER GENE;

ANIMALS; BETA-GALACTOSIDASE; BONE NEOPLASMS; BUTYRIC ACID; BUTYRIC ACIDS; ENZYME INDUCTION; ENZYME INHIBITORS; GENES, REPORTER; HISTONE DEACETYLASES; HYDROXAMIC ACIDS; OSTEOSARCOMA; PHENYLBUTYRATES; PLASMIDS; PROPIONIC ACIDS; RATS; RECOMBINANT PROTEINS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0031865432     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Herbomel P, Bourachot B and Yaniv M: Two distinct enhancers with different cell specificities coexist in the regulatory region of polyoma. Cell 39: 653-662, 1984.
2. Schwachtgen J-L, Ferreira V, Meyer D and Kerbiriou-Nabias D: Optimization of the transfection of human endothelial cells by electroporation. Biotechniques 17: 882-885, 1994.
3. Gill RK and Christakos S: Identification of sequence elements in mouse calbindin-D28k gene that confer 1,25-dihydroxyvitamin D3-and butyrate-inducible responses. Proc Natl Acad Sci USA 90: 2984-2988, 1993.
4. Riggs MG, Whittaker RG, Neumann JR and Ingram VM: n-Butyrate causes histone modification in HeLa and Friend erythroleukemia cells. Nature 268: 462-464, 1977.
5. Boffa LC, Vidali G, Mann RS and Allfrey VG: Suppression of histone deacetylation in vivo and in vitro by sodium butyrate. J Biol Chem 253: 3364-3366, 1978.
6. Reeves R and Candido EPM: Turnover of histone acetyl groups in cultured cells is inhibited by sodium butyrate. FEBS Lett 91: 117-120, 1978.
7. Sealy L and Chalkley R: The effect of sodium butyrate on histone modification. Cell 14: 115-121, 1978.
8. Yoshida M, Kijima M, Akita M and Beppu T: Potent and specific inhibition of mammalian histone deactylase both in vivo and in vitro by trichostatin A. J Biol Chem 265: 17174-17179, 1990.
9. Yoshida M, Nomura S and Beppu T: Effects of trichostatins on differentiation of murine erythroleukemia cells. Cancer Res 47: 3688-3691, 1987.
10. Conley B, Tait N, Rosen D, Sausville E, Van Echo E and Egorin M: Phase I and pharmacokinetic trial of oral tributyrin in patients with solid tumors. Proc Am Assoc Cancer Res 38: 222, 1997.
11. Smigel K: Non-toxic drug being tested to treat cancer and anemias. J Natl Cancer Inst 84: 1398-1399, 1992.
12. Samid D, Shack S and Sherman LT: Phenylacetate: a novel nontoxic inducer of tumor cell differentiation. Cancer Res 52: 1988-1992, 1992.
13. Samid D, Yeh A and Prasanna P: Induction of erythroid differentiation and fetal hemoglobin production in human leukemic cells treated with phenylacetate. Blood 80: 1576-1581, 1992.
14. Lea MA and Tulsyan N: Discordant effects of butyrate analogues on erythroleukemia cell proliferation, differentiation and histone deacetylase. Anticancer Res 15. 879-884, 1995.
15. Wade PA, Pruss D and Wolffe AP: Histone acetylation: chromatin in action. TIBS, 22: 128-131, 1997.
16. Pazin MJ and Kadonaga JT: What's up and down with histone deacetylation and transcription? Cell 89: 325-328, 1997.
17. Smith JG, German JB and Hickman MA: Incorporation of tributyrin enhances the expression of a reporter gene in primary and immortalized cell lines. Biotechniques 18: 852-855, 1995.
18. Olivieri NF, Rees DC, Ginder GD, Thein SL, Brittenham GM, Waye JS and Weatherall DJ: Treatment of thalassaemia major with phenylbutyrate and hydroxyurea. Lancet 350: 491-492, 1997.
19. Piscitelli SC, Thibault A, Figg WD, Tompkins A, Headlee D, Lieberman R, Samid D, and Myers CE: Disposition of phenylbutyrate and its metabolites, phenylacetate and phenylacetylglutamine. J Clin Pharmacol 35: 368-373, 1995.
20. Miller AC, Whittaker T, Thibault A and Samid D: Modulation of radiation response of human tumour cells by the differentiation inducers, phenylacetate and phenylbutyrate. Int J Radiat Biol 72: 211-218, 1997.
21. Gorospe M, Shack S, Guyton KZ, Samid D and Holbrook NJ: Up-regulation and functional role of p21wAFI/cipl during growth arrest of human breast carcinoma MCF-7 cells by phenylacetate. Cell Growth Diff 7: 1609-1615, 1996.
22. Huang Y and Waxman S: Enhanced p21waf1 expression, differentiation, and growth inhibition of human colon carcinoma cell lines result from combined treatment with Interferon γ and phenylbutyrate. Proc Am Assoc Cancer Res 38: 87, 1997.
23. Liu L, Kulkarni M, Thibault A and Samid D: Down-regulation of cyclin D1 expression in human glioma cells by the differentiation inducers phenylacetate and phenylbutyrate. Proc Am Cancer Res 38: 87, 1997.
24. Shack S, Chen L-C, Miller AC, Danesi R and Samid D: Increased susceptibility of ras-transformed cells to phenylacetate is associated with inhibition of p21ras isoprenylation and phenotypic reversion. Int J Cancer 63: 124-129, 1995.
25. Carstea ED, Miller SPF, Christakis H and O'Neill RR: Analogues of butyric acid that increase the expression of transfected DNAs. Biochem Biophys Res Commun 192: 649-656, 1993.
26. Bohan CA, Robinson RA, Luciw PA and Srinivasan A: Mutational analysis of sodium butyrate inducible elements in the human immunodeficiency virus type I long terminal repeat.Virology 172: 573-583, 1989.
27. Klehr D, Schlake T, Maass K and Bode J: Scaffold-attached regions (SAR elements) mediate transcriptional effects due to butyrate. Biochemistry 31: 3222-3229, 1992.
28. Nakano K, Mizuno T, Sowa Y, Orita T, Yoshino T, Okuyama Y, Fujita T, Ohtani-Fujita N, Matsukawa Y, Tokino T, Yamagishi H, Oka T, Nomura H and Sakai T: Butyrate activates the WAF1/Cipl gene promoter through Sp1 sites in a p53 negative human colon cancer cell line. J Biol Chem 272: 22199-22206, 1997.
29. Sambrook J, Fritsch EF and Maniatis T: Molecular Cloning. A Laboratory Manual, Second Edition, Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989, pp. 1.38-1.39.
30. Ausubel FM, Brent R, Kingston RE, Moor DD, Seidman JG, Smith JA and Struhl K: Current Protocols in Molecular Biology, Vol. 1, New York: Wiley Interscience, 1991, pp. 9.1.1-9.1.3.
31. Panyim S and Chalkley R: High resolution acrylamide gel electrophoresis of histones. Arch Biochem Biophys 130: 337-346, 1969.